Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Immunic, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 65 | 56 | −9 |
| Shares | 40.5M | 50.2M | +9.70M (+24.0%) |
| Value | $44.1M | $35.0M | −$9.11M (−20.6%) |
New holders (5)
Institutions that held Immunic, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ghisallo Capital Management LLC | 835,000 | $582.4K | 0.02% |
| RTW Investments, LP | 402,107 | $280.5K | 0.00% |
| Strategies Wealth Advisors, LLC | 100,000 | $69.8K | 0.01% |
| Raymond James Financial Inc | 2,025 | $1.41K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,007 | $1.40K | 0.00% |
Sold out (14)
Institutions that held Immunic, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 949,648 | $1.04M |
| Jane Street Group, LLC | 207,401 | $226.1K |
| Gsa Capital Partners LLP | 177,381 | $193.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 120,027 | $130.8K |
| Envestnet Asset Management Inc | 55,114 | $60.1K |
| HB Wealth Management, LLC | 52,400 | $57.1K |
| Schonfeld Strategic Advisors LLC | 45,774 | $49.9K |
| Quadrature Capital Ltd | 44,536 | $48.1K |
| Jain Global LLC | 36,622 | $39.9K |
| Invesco Ltd. | 35,409 | $38.6K |
| Qube Research & Technologies Ltd | 34,989 | $38.1K |
| Cubist Systematic Strategies, LLC | 14,742 | $16.1K |
| Hudson Bay Capital Management LP | 14,573 | $15.9K |
| Rise Advisors, LLC | 862 | $940 |